ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

Family History of BRCA Mutation Does Not Equal Increased Risk

October 28, 2011

In Brief: Breast Cancer Stamp Unveiled; Payne Moves To MSK; Survivor To Bike Across U.S.

July 31, 1998

Draft of National Action Plan On Breast Cancer Targets Health Care, Research, Policy

March 23, 1994

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

Symposium Planned On Grantmanship

April 20, 1984